HRAS and Alzheimer disease: Together, these results indicate that Dfb-applied HrasG12S/+ mice exhibited more severe AD-like skin lesions than Hras+/+ mice, including acanthosis with hyperproliferation of p-ERK-positive cells in the epidermis, as well as increased inflammatory cells and reduced claudin-1 expression.